Search Results - "McAdams, Meredith J"
-
1
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors
Published in JTO clinical and research reports (01-10-2021)“…Defects in immunologic self-tolerance result in an increased risk for development of paraneoplastic autoimmune diseases (ADs) and immune-mediated toxicity in…”
Get full text
Journal Article -
2
Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword
Published in Cancers (20-04-2022)“…Thymic epithelial tumors (TETs) are rare thoracic cancers that are broadly classified as thymomas and thymic carcinomas. Surgery is the cornerstone of…”
Get full text
Journal Article -
3
Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions
Published in Cancers (01-04-2024)“…Thymic epithelial tumors are a histologically diverse group of cancers arising from the epithelial compartment of the thymus. These tumors are characterized by…”
Get full text
Journal Article -
4
Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist’s perspective
Published in Mediastinum (Hong Kong, China) (25-09-2022)Get full text
Journal Article -
5
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors
Published in The oncologist (Dayton, Ohio) (05-04-2022)“…Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced cancers. However, activation of the immune system can occasionally cause…”
Get full text
Journal Article -
6
Caregiver-assisted coping skills training for patients with COPD: background, design, and methodological issues for the INSPIRE-II study
Published in Clinical trials (London, England) (01-04-2009)“…Background Chronic Obstructive Pulmonary Disease (COPD) is a progressive illness characterized by airflow obstruction and dyspnea that afflicts over 12 million…”
Get full text
Journal Article -
7
Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation
Published in Blood (05-11-2021)“…Abstract Background: Post-transplantation cyclophosphamide (PTCy) is widely used for graft-versus-host-disease (GVHD) prophylaxis after hematopoietic cell…”
Get full text
Journal Article -
8
AB011. Quantification of thymic epithelial tumor volumes through deep learning
Published in Mediastinum (Hong Kong, China) (30-12-2023)Get full text
Journal Article -
9
-
10
AB013. Tolerability of COVID-19 mRNA vaccines in patients with thymic epithelial tumors
Published in Mediastinum (Hong Kong, China) (30-12-2021)Get full text
Journal Article -
11